Piper Sandler initiated coverage on soda stocks, rating PepsiCo (NASDAQ:PEP), Coca-Cola (NYSE:KO) “overweight,” and Neutral on Keurig Dr Pepper (NASDAQ:KDP).
Phase 1 results support proceeding to Phase 2 in patients with post-bariatric hypoglycemia (PBH), which is expected to begin in 2H 2025 Phase 1 trial in healthy volunteers showed MBX 1416 was generall ...
Some results have been hidden because they may be inaccessible to you